New Biomarker Discovery May Boost Obesity Treatment
Researchers have identified a protein fragment called endotrophin that fluctuates in response to changes in body fat mass. This biomarker could help scientists better understand metabolic health and develop new treatments for obesity-related complications.
Why it matters
Discovering a reliable biomarker for fat mass changes provides a new target for medical interventions to combat the global obesity epidemic.
Researchers have identified a biological marker that rises and falls as body fat changes, offering new insight into how weight gain and weight loss may influence metabolic health.
Published in Metabolism, the study " Dynamic Regulation of Circulating Endotrophin by Changes in Fat Mass in Humans " found that circulating levels of endotrophin - a protein fragment released as fat tissue expands and remodels - consistently increased when people gained body fat and decreased when they lost body fat. The findings suggest endotrophin could serve as a valuable biomarker of metabolic health and may one day become a target for therapies aimed at reducing the health risks associated with obesity.
The study included researchers from LSU's Pennington Biomedical Research Center, Pontificia Universidad Cat lica de Chile, Touchstone Diabetes Center at the University of Texas Southwestern and Texas Therapeutics Institute at the University of Texas Health Science Center at Houston.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in